Francesco Della Valle

This inventor holds 93 USPTO granted patents and 16 published patent applications, plus 15 CIPO patents and 24 EPO patents, primarily in Pharmaceutical Compositions (CPC class 514 54). Top assignees: Fidia S.p.a., Lifegroup S.p.a., Epitech Group S.r.l.. Active years: 1981-2025.

USPTO Granted Patents = 93 (Patent Applications = 16)

% Patents Active = 97.8

CIPO Patents = 15 (Patent Applications = 4)

EPO Patents = 24 (Patent Applications = 20)

Average Co-Inventor Count = 2.4

ph-index = 20

Forward Citations = 2,093(Granted Patents)

Forward Citations (Not Self Cited) = 1,989(Dec 10, 2025)

Inventors with similar research interests:

Aurelio Romeo

Location History:

Paduva, IT (1989)
Padova, IT (1986 - 2013)
Padua, IT (1981 - 2014)
Milan, IT (2016 - 2023)

Company Filing History:

Innovet Italia S.r.l.

patents

6. 1 out of 31

Consiglio Nazionale Delle Richerche

patents

7. 1 out of 7

Epitech Corporation, Ltd.

patents

where one patent can have more than one assignee

Years Active: 1981-2025

Loading Chart...

Areas of Expertise:

Palmitoylethanolamide

Acylethanolamides

N-acyl Derivatives

Pharmaceutical Compositions

Pain Management

COVID-19 Treatment

Acne Treatment

Micronized Formulations

Topical Preparations

Hyaluronic Acid

Biocompatible Membranes

Inflammatory Diseases

93 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12370157 - Method for the treatment of COVID-19 infections with palmitoylethanolamide (2025-07-29),

2. 12364678 - Pharmaceutical composition comprising palmitoylethanolamide and L- Acetylcarnitine (2025-07-22),

3. 12102608 - Composition of acylethanolamides from olive oil fatty acids (2024-10-01),

4. 11819511 - Composition of N-palmitoyl-ethanolamide and Rutin in co-micronized form (2023-11-21),

5. 11744840 - N-palmitoyl-D-glucosamine in a micronized form (2023-09-05),

6. 11491122 - Use of a combination of Adelmidrol and hyaluronic acid in the treatment of pain caused by osteoarthritis and epithelial dysfunctions (2022-11-08),

7. 10441559 - Method of treating neuropathic pain with a synergistic pharmaceutical composition comprising palmitoylethanolamide and L-acetylcarnitine (2019-10-15),

8. 9801836 - Using palmitoylethanolamide in combination with opioids (2017-10-31),

9. 9668986 - Ophthalmic, intra-articular or intravesical preparations containing N-acyl-ethanolamines (2017-06-06),

10. 9522192 - Polyethylene glycol derivatives of palmitoylethanolamide and analogous acylethanolamides (2016-12-20),

11. 9512091 - Compositions and methods for the modulation of specific amidases for N-acylethanolamines for use in the therapy of inflammatory diseases (2016-12-06),

12. 9402818 - Use of amides of mono- and dicarboxylic acids in the treatment of renal diseases (2016-08-02),

13. 9399031 - Combined use of amides of mono- and dicarboxylic acids and silymarin in the treatment of renal diseases (2016-07-26),

14. 8663701 - Compositions containing ultra-micronized palmitoyl-ethanolamide (2014-03-04),

15. 8546352 - Pharmacological preparation for topical use containing N-palmitoyl-vanillamide (2013-10-01),

Title: Francesco della Valle: A Pioneer of Innovation in Technology

Introduction:

Francesco della Valle, a prominent inventor based in Padova, Italy, has distinguished himself as a trailblazer in the field of technology. With a portfolio of 60 patents to his name, he has significantly contributed to advancements in various domains.

Latest Patents:

Francesco della Valle's latest patents showcase his ingenuity and focus on pharmaceutical applications. One notable patent is the therapeutic use of mono and bicarboxylic acid amides active at the - Hyaluronic acid fractions. These fractions have pharmaceutical activity, with one being useful for wound healing and the other for intraocular and intraarticular injections.

Career Highlights:

Throughout his career, Francesco della Valle has made significant strides in the technology sector. His innovative approach has led to groundbreaking inventions that have had a profound impact on society. Working with companies like Fidia S.p.A. and Lifegroup S.p.A., he has been at the forefront of cutting-edge research and development.

Collaborations:

Francesco della Valle's collaborations with esteemed colleagues, such as Aurelio Romeo and Silvana Lorenzi, have further fueled his innovative spirit. Together, they have embarked on projects that have pushed the boundaries of technological advancements and paved the way for new discoveries in the field.

Conclusion:

In conclusion, Francesco della Valle stands as a beacon of innovation in the field of technology, with a remarkable track record of patents and inventions that have left a lasting impact on society. His relentless pursuit of excellence continues to inspire aspiring inventors worldwide.